Can reused heart catheters cut costs and waste without risking patient safety?

NCT ID NCT07389434

Recruiting now Disease control Sponsor: University Hospital Dubrava Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares reprocessed (cleaned and re-sterilized) ablation catheters to brand-new ones in 200 adults with atrial fibrillation undergoing pulmonary vein isolation. The goal is to see if the reused catheters are just as safe and effective, while also being cheaper and better for the environment. Participants are randomly assigned to receive either a new or reprocessed catheter, and the research team will measure procedure time, safety, costs, and waste.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: reprocessed ablation catheter
What this could lead to: If successful, this could show that reprocessed catheters are a safe, cheaper, and more eco-friendly option for treating atrial fibrillation.
What could go wrong: This is a feasibility study, not a large-scale trial. Reprocessed catheters may have higher failure or infection risks, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION (AF)

Contacts and locations

Locations

UH Dubrava
RECRUITING

Zagreb, 10000, Croatia

More trials for these conditions

Other studies related to the condition(s) this trial covers.